Related Experiment Videos
[Immunohistochemical identification of proliferating cell nuclear antigen (PCNA) in hematological disorders]
Insights
Immunohistochemical identification of proliferating cell nuclear antigens (PCNA) aids in diagnosing hematological disorders. This method effectively detects PCNA in various hematopoietic cells, offering crucial diagnostic information.
Area of Science:
- Hematology
- Immunohistochemistry
- Cell Biology
Context:
- Hematological disorders involve abnormal cell proliferation.
- Accurate diagnosis and monitoring are crucial for patient outcomes.
- Immunohistochemistry offers a method for cellular analysis.
Purpose:
- To evaluate the utility of proliferating cell nuclear antigens (PCNA) immunohistochemistry in diagnosing hematological disorders.
- To assess PCNA expression in various hematopoietic cells using short-term fixation methods.
Summary:
- Bone marrow smears were analyzed using immunohistochemistry to detect PCNA in hematopoietic cells.
- Short-term buffered acetone formalin fixation enabled clear visualization of cell morphology and PCNA.
- PCNA was identified in erythroblasts, megakaryocytes, plasma cells, and blasts, distinguishing varying levels of proliferation in leukemia.
Impact:
- PCNA immunohistochemistry provides valuable diagnostic information for hematological malignancies.
- This technique can aid in distinguishing between different subtypes and assessing disease progression.
- Future applications may include improved diagnostic accuracy and patient monitoring strategies.
Abstract:
We used bone marrow smears to examine how immunohistochemical identification of PCNA (proliferating cell nuclear antigens) which markers of proliferation, works for various hematopoietic cells in hematological disorders. Short-term fixation with buffered acetone formalin allowed us not only to observe morphosis properly but also to identify the occurrence of PCNA in erythroblasts, megakaryocytes, plasma cells and blasts. For blasts of leukemia patients, we could distinguish more positive cases from less positive ones regardless of the increase or decrease of cells. A change in PCNA due to the existence of neoplastic cells was also observed. These findings suggest that in the future, analyzing the occurrence of PCNA in hematopoietic cells can provide us with immunohistochemically important information on diagnosis of malignancy and follow up.